Megestrol acetate and Synovitis - a phase IV clinical study of FDA data

Summary:

Synovitis is reported as a side effect among people who take Megestrol acetate (megestrol acetate), especially for people who are female, 50-59 old, also take Zometa, and have Breast cancer.

The phase IV clinical study analyzes which people have Synovitis when taking Megestrol acetate. It is created by eHealthMe based on reports of 5,359 people who have side effects when taking Megestrol acetate from the FDA, and is updated regularly.

What is Megestrol acetate?

Megestrol acetate has active ingredients of megestrol acetate. It is often used in appetite - decreased. eHealthMe is studying from 5,427 Megestrol acetate users. Check the latest studies of Megestrol acetate.

What is Synovitis?

Synovitis (inflammation of the synovial membrane) is found to be associated with 694 drugs and 511 conditions by eHealthMe. Check the latest studies of Synovitis.

On Jul, 21, 2026

5,359 people reported to have side effects when taking Megestrol acetate.
Among them, 30 people (0.56%) have Synovitis.

Could Megestrol acetate cause Synovitis?

Among these 30 people:

What is the gender of people who have Synovitis when taking Megestrol acetate? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Synovitis when taking Megestrol acetate? *

What are other drugs people take besides Megestrol acetate? *

What are other side effects people have besides Synovitis? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 30 people, 100.00%
Injury: 30 people, 100.00%
Weakness: 29 people, 96.67%
Osteonecrosis Of Jaw (death of bone of jaw): 28 people, 93.33%
Fungal Nail Infection: 26 people, 86.67%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 26 people, 86.67%
Joint Pain: 26 people, 86.67%
Intervertebral Disc Protrusion (spinal disc protrusion): 25 people, 83.33%
Anaemia (lack of blood): 25 people, 83.33%
Spinal Osteoarthritis (joint cartilage loss in spine): 25 people, 83.33%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 17 people, 56.67%
Neoplasm Malignant (cancer tumour): 17 people, 56.67%
Migraine (headache): 17 people, 56.67%
Discomfort: 17 people, 56.67%
Breast Cancer Metastatic: 17 people, 56.67%
Breast Cancer: 17 people, 56.67%
Granulocyte Count Decreased: 16 people, 53.33%
Prostate Cancer Metastatic: 4 people, 13.33%
Metastatic Neoplasm (spreadable cancer tumour): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Megestrol acetate and have Synovitis?

- Check whether Synovitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Megestrol acetate:

Megestrol acetate (5,427 reports)

Synovitis treatments and more:

Synovitis (24,130 reports)

Browse all side effects of Megestrol acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Synovitis:

Synovitis (694 drugs)

Browse all the conditions that are associated with Synovitis:

Synovitis (511 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on megestrol acetate (the active ingredients of Megestrol acetate) and Megestrol acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.